Anika Therapeutics Inc banner

Anika Therapeutics Inc
NASDAQ:ANIK

Watchlist Manager
Anika Therapeutics Inc Logo
Anika Therapeutics Inc
NASDAQ:ANIK
Watchlist
Price: 14.36 USD 1.13% Market Closed
Market Cap: $207.1m

Balance Sheet

Balance Sheet Decomposition
Anika Therapeutics Inc

Balance Sheet
Anika Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
9
11
15
39
45
47
36
43
24
28
36
44
63
100
111
104
133
89
158
96
94
86
73
56
Cash Equivalents
9
11
15
39
45
47
36
43
24
28
36
44
63
100
111
104
133
89
158
96
94
86
73
56
Short-Term Investments
4
3
0
0
0
0
4
0
0
0
0
0
0
7
28
21
24
70
28
3
0
0
0
0
Total Receivables
2
1
1
2
2
4
6
5
12
15
17
22
19
17
22
28
24
21
23
24
30
35
36
24
Accounts Receivables
2
1
1
2
2
4
6
5
12
15
17
22
19
17
22
28
24
21
23
24
30
35
36
24
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
4
3
4
4
3
5
4
6
9
9
7
8
11
12
15
16
22
21
22
46
36
40
46
24
Other Current Assets
1
0
1
3
2
2
3
2
5
4
4
4
2
3
1
2
3
2
4
9
8
9
8
11
Total Current Assets
20
18
21
49
52
58
52
56
50
56
64
77
95
139
176
170
206
203
234
177
169
170
163
114
PP&E Net
3
2
1
1
2
3
19
32
36
37
37
35
33
32
40
52
56
54
74
73
69
79
75
65
PP&E Gross
3
2
1
1
2
3
19
32
36
37
37
35
33
32
40
52
56
54
74
73
69
79
75
65
Accumulated Depreciation
7
8
9
9
10
10
9
10
11
13
14
17
20
22
25
27
20
24
29
35
40
46
48
46
Intangible Assets
0
0
0
0
0
0
1
1
30
26
23
20
19
15
12
10
11
9
8
91
82
75
5
2
Goodwill
0
0
0
0
0
0
0
0
10
9
9
9
9
8
8
7
8
8
8
8
8
7
8
7
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
Other Long-Term Assets
0
0
0
10
8
8
7
7
4
1
0
0
0
0
0
0
1
5
8
15
20
19
20
9
Other Assets
0
0
0
0
0
0
0
0
10
9
9
9
9
8
8
7
8
8
8
8
8
7
8
7
Total Assets
23
N/A
20
-12%
22
+9%
60
+172%
63
+5%
68
+9%
80
+17%
96
+21%
129
+35%
129
0%
133
+3%
142
+7%
156
+10%
194
+24%
236
+21%
240
+2%
283
+18%
279
-1%
331
+19%
366
+11%
348
-5%
349
+0%
271
-22%
203
-25%
Liabilities
Accounts Payable
1
1
0
1
1
1
5
2
6
10
4
2
3
1
8
2
7
3
4
9
8
9
10
6
Accrued Liabilities
2
2
1
2
2
2
3
2
6
5
5
6
6
5
5
7
6
8
12
15
18
18
20
14
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
1
0
4
3
3
3
3
3
3
3
5
1
0
4
0
0
0
0
13
4
1
1
4
Total Current Liabilities
3
3
2
7
6
6
11
9
17
19
15
15
9
6
17
9
13
11
16
37
30
28
31
23
Long-Term Debt
0
0
0
0
0
0
0
14
13
11
10
8
0
0
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
8
6
7
7
8
9
7
7
5
4
4
12
10
6
0
0
Other Liabilities
0
0
2
22
19
17
14
12
10
7
7
4
3
1
1
2
1
1
22
44
21
29
27
25
Total Liabilities
3
N/A
3
+7%
4
+30%
29
+649%
25
-15%
23
-9%
25
+8%
35
+43%
47
+35%
44
-8%
38
-13%
33
-13%
20
-38%
16
-22%
25
+57%
18
-30%
19
+9%
15
-19%
42
+175%
93
+120%
61
-35%
64
+5%
58
-8%
49
-16%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
11
14
14
2
4
8
14
18
22
26
34
46
67
105
136
168
200
218
245
221
226
211
128
72
Additional Paid In Capital
32
32
32
33
34
37
41
43
61
62
63
65
71
78
82
62
69
51
49
55
67
81
90
89
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
3
3
3
2
5
7
7
5
6
6
5
6
6
6
7
Total Equity
20
N/A
17
-15%
18
+5%
30
+69%
38
+25%
46
+20%
55
+21%
61
+11%
82
+35%
85
+4%
95
+11%
109
+15%
136
+25%
178
+31%
211
+18%
223
+6%
264
+18%
264
+0%
288
+9%
272
-6%
287
+5%
286
-1%
212
-26%
154
-27%
Total Liabilities & Equity
23
N/A
20
-12%
22
+9%
60
+172%
63
+5%
68
+9%
80
+17%
96
+21%
129
+35%
129
0%
133
+3%
142
+7%
156
+10%
194
+24%
236
+21%
240
+2%
283
+18%
279
-1%
331
+19%
366
+11%
348
-5%
349
+0%
271
-22%
203
-25%
Shares Outstanding
Common Shares Outstanding
10
10
10
10
11
11
11
11
13
14
14
14
14
15
15
15
15
14
14
14
14
15
15
14
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett